Compounds > furylfuramide
Page last updated: 2024-08-22

furylfuramide and Cancer of Pituitary

furylfuramide has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aranda, A; Castillo, AI; Jimenez-Lara, AM; Tolon, RM1

Other Studies

1 other study(ies) available for furylfuramide and Cancer of Pituitary

ArticleYear
Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
    Molecular endocrinology (Baltimore, Md.), 1999, Volume: 13, Issue:7

    Topics: Animals; Base Sequence; CREB-Binding Protein; Dimerization; DNA-Binding Proteins; Furylfuramide; HeLa Cells; Histone Acetyltransferases; Humans; Molecular Sequence Data; Mutation; Nuclear Proteins; Nuclear Receptor Coactivator 1; Pituitary Neoplasms; Prolactin; Promoter Regions, Genetic; Rats; Receptors, Calcitriol; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Trans-Activators; Transcription Factor Pit-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Vitamin D

1999